🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Acute Lymphobkastic Leukemia

A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase NCT06600659n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia NCT07258043n/a1 site📍 Mexico City Hospital General de Mexico · Tests: Patients meeting criteria will receive DA-EPOCH via central line for 5 days every 21 days, with monitoring, supportive … Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients NCT07039877Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Venetoclax low dose with itraconazole Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia NCT07899840n/a3 sites📍 Vienna📍 Monza📍 Padova Fondazione Matilde Tettamanti Menotti De Marchi Onlus
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy